EMAIL DETAILS

Share The View a:visited { color: #00b9e7; } a:hover { text-decoration: underline !important; } a:hover#logo { text-decoration: none !important; } @media only screen and (max-device-width: 480px) { a[id=logo] { font-size: 34px !important; } body { width: 100% !important; } table { width: 100% !important; } } @media only screen and (min-device-width: 320px) and (max-device-width: 568px) { html { -webkit-text-size-adjust: auto; } td[id=content] { font-size: 18px !important; } body { width: 100% !important; } table { width: 100% !important; } } Share The View The Latest Opinions From Bloomberg View May 20, 2016 bloombergview.com Leaving Europe Is a Gamble the UK Shouldn't Make
No one knows quite what would happen if Great Britain broke off from the European Union this summer, but the consequences would be far-reaching. Michael R. Bloomberg says that on matters economic and diplomatic, the risk isn't worth the reward.
Theranos Could Have Used a Few Short Sellers
Credulous investors, regulators and journalists might have overlooked red flags at the unicorn blood-testing startup, which recently had to throw out two years of results from its proprietary devices -- but Justin Fox says short sellers would have had reason to raise hell.
Donald Trump Tries to Soothe the Womenfolk
The presumptive Republican nominee isn't too popular with the ladies, and he knows it. Margaret Carlson analyzes Trump's attempt to heal the rift with Megyn Kelly, Fox News and 51 percent of the population.
A 50-Year U.S. Bond Makes More Sense Than Ever
Barry Ritholtz says now is the time to issue debt that takes advantage of near-record low rates, while financing the country's long-term obligations.
Doctors Have a Right (and a Duty) to Ask About Guns
Sometimes, taking care of public health means asking patients about their personal habits -- or their firearms. The Bloomberg View editorial board condemns gun-lobby-backed laws that restrict what physicians can and can't discuss with their patients.
Ritholtz's Reads

The overconfident enemy in the mirror (ETF.com)
S&P 500: world's largest momentum strategy (A Wealth of Common Sense)
The real reason big pharma wants to help pay for your prescription (Businessweek)

(Read Barry Ritholtz's full daily news roundup.)
Bloomberg Gadfly

Death of IPOs could spell the end of the tech boom
ETF investors shun roller coasters for kiddie rides
Home improvement companies can thank the housing bust

(Read more from BV's sister site for fast business commentary.) For more information, email view@bloomberg.net. For media inquiries, contact Jill Watanabe at +1-212-617-1610 or jwatanabe11@bloomberg.net. You received this message because you signed up for Bloomberg View newsletters. bloombergview.com | 731 Lexington Avenue, New York, NY 10022 | Contact Us | Unsubscribe <a href="http://link.mail.bloombergview.com/click/6761921.24123/aHR0cDovL3d3dy5tYWlsLmJsb29tYmVyZ3ZpZXcuY29tIg/55086a4c3b35d051538c37ccB254ec645><img src="http://link.mail.bloombergview.com/img/55086a4c3b35d051538c37cc40xj5.im3/4bd6b286.gif" alt="" border="0" /></a>

If you believe this has been sent to you in error, please click <http://link.mail.bloombergview.com/oc/55086a4c3b35d051538c37cc40xj5.im3/5bf67885> to safely unsubscrib